Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases
Authors:
- Mete Bora TüzünerMete Bora Tüzüner
- Mete BoraMBMete Bora
- ÖztürkÖZÖztürk
- TülinTÜTülin
- Halil İbrahimHIHalil İbrahim
- Hande TurnaHande Turna
- 30 June 2016
- journal article
- research article
- Published by Springer Nature in Biochemical Genetics
- Vol. 54 (6) , 784-802
Abstract
There is growing attention focused on local estrogen production in the breast tissue and its possible role in breast cancer initiation and progression. Understanding the underlying mechanisms for estrogen synthesis and the microenvironment consisting of tumor and its surrounding adipose tissue might open new avenues in breast cancer prevention, prognosis and treatment. In order to obtain insight, we compared peritumoral and tumor tissue expressions of CYP17A1 and CYP19A1 genes, which play an important role in estrogen biosynthesis. The paired tissue samples of 20 postmenopausal ER+/PR+ patients diagnosed with invasive ductal breast cancer were studied. In addition, 12 breast tissue samples obtained from premenopausal women without a history of breast cancer were also investigated as representative of normal conditions. Peritumoral adipose tissues expressed CYP19A1 approximately threefold higher than tumor itself (p = 0.001). A nonsignificant trend toward low expression of CYP17A1 was observed in peritumoral compared to tumor tissue (p = 0.687). Clinicopathological parameters and patient characteristics which are accepted as risk factors for breast cancer were also associated with individual and combined expressions of CYP17A1 and CYP19A1. This study offers that evaluation of CYP17A1 and CYP19A1 local expression levels might be useful for deciding on personalized treatment approaches and more accurate diagnosis, when evaluated together with several clinicopathological and disease risk factors. Considering the key role of these CYPs in estrogen synthesis, determining their expression levels may be useful as a postdiagnostic marker and for choosing the right treatment method in addition to the conventional approach.Keywords
Funding Information
- The Scientific Research Projects Coordination Unit of Istanbul Technical University (36004)
This publication has 35 references indexed in Scilit:
- Aromatase in Nontumoral and Malignant Human Liver Tissues and CellsAnnals of the New York Academy of Sciences, 2009
- Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study ProjectCarcinogenesis, 2008
- Aromatase Expression in Women’s Cancers2008
- Pregnancy and the risk of breast cancerEndocrine-Related Cancer, 2007
- Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI: Journal of the National Cancer Institute, 2005
- Estrogen and the Risk of Breast CancerNew England Journal of Medicine, 2001
- Intratumoral levels of estrogens in breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1999
- Endocrine disorders associated with inappropriately high aromatase expressionThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Tumor-related prognostic factors for breast cancerCA: A Cancer Journal for Clinicians, 1997
- Metabolism of pregnenolone by human breast cancer. Evidence for 17α-hydroxylase and 17,20-lyaseSteroids, 1979